Changhai Lei
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Extracellular vesicles in disease 8
- Oncology 13
- CAR-T cell therapy research 7
- Co-authors
- Shi Hu (24 shared papers)Wenyan Fu (20 shared papers)Kewen Qian (11 shared papers)Min Ding (6 shared papers)Li Tian (3 shared papers)Yafeng Shen (11 shared papers)Fangxing Lin (10 shared papers)Sheng Zhang (1 shared paper)
- Journals
- Frontiers in Immunology (7 papers)Nature Communications (2 papers)Journal of drug targeting (2 papers)Clinical Cancer Research (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Changhai Lei
30 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 243
- Infectious Diseases 295
- Immunology 282
- Oncology 270
- Molecular Biology 588
Countries citing papers authored by Changhai Lei
This map shows the geographic impact of Changhai Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhai Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhai Lei more than expected).
Fields of papers citing papers by Changhai Lei
This network shows the impact of papers produced by Changhai Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhai Lei. The network helps show where Changhai Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Changhai Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity Hit paper breakdown → | 2019 | 389 |
| 2 | 2020 | 300 | |
| 3 | 2017 | 57 | |
| 4 | 2015 | 52 | |
| 5 | 2022 | 49 | |
| 6 | 2019 | 29 | |
| 7 | 2019 | 27 | |
| 8 | 2021 | 25 | |
| 9 | 2016 | 22 | |
| 10 | 2024 | 19 | |
| 11 | 2017 | 19 | |
| 12 | 2024 | 19 | |
| 13 | 2024 | 18 | |
| 14 | 2009 | 14 | |
| 15 | 2022 | 12 | |
| 16 | 2021 | 10 | |
| 17 | 2024 | 10 | |
| 18 | 2021 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2017 | 9 |
About Changhai Lei
Changhai Lei is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (5 papers), MicroRNA in disease regulation (3 papers), Viral Infections and Immunology Research (3 papers), Immune Cell Function and Interaction (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Cancer Research (243 citations), Infectious Diseases (295 citations), Immunology (282 citations), Oncology (270 citations) and Molecular Biology (588 citations). Changhai Lei has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Shi Hu, Wenyan Fu, Kewen Qian, Min Ding, Li Tian, Yafeng Shen, Fangxing Lin, Sheng Zhang, Yongji Yang and Xiaoyan Fan. Their work appears in journals such as Frontiers in Immunology, Nature Communications, Journal of drug targeting, Clinical Cancer Research and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.